Read the latest positive news, breakthroughs, and inspiring stories about cancer breakthrough, curated daily by BrightWire.
A simple patch the size of a Band-Aid is now treating non-melanoma skin cancer with a 95% success rate, requiring just five days instead of weeks of traditional treatment. Doctors at UC San Diego Health are among the first in the country to use the FDA-approved innovation.
Researchers at the University of Alabama discovered how aggressive neuroblastoma spreads and found two drug targets that dramatically slowed tumor growth in testing. This breakthrough offers new hope for the 600 to 800 children diagnosed with this deadly cancer each year.
A simple blood test is cracking cases of "mystery cancer" that once took months to diagnose, giving desperate patients fighting chances when time matters most. One Hong Kong mother got answers in 10 days instead of endless biopsies.
A groundbreaking pancreatic cancer treatment just won FDA approval, offering new hope to thousands of patients. The drug Rasonque represents a major step forward in fighting one of the deadliest cancers.
The FDA just approved a groundbreaking pill that nearly doubles survival time for advanced pancreatic cancer patients, cracking a problem scientists couldn't solve for decades. The drug targets a mutated protein driving more than 90% of these cancers.
A personalized mRNA cancer vaccine prevented deadly skin cancer from returning in over a thousand patients, marking the first successful Phase 3 trial for custom cancer treatment. The breakthrough could reach patients as soon as next year.
A personalized vaccine combined with existing cancer treatment stopped skin cancer from coming back in over 1,000 patients during a major clinical trial. Scientists used the same mRNA technology from COVID vaccines to create custom treatments targeting each patient's unique tumor.
A personalized mRNA cancer vaccine combined with existing treatment stopped melanoma from returning in a major clinical trial. The breakthrough could open a powerful new way to fight cancer using the same technology that powered COVID vaccines.
A groundbreaking personalized vaccine combined with an existing drug stopped skin cancer from returning in over 1,000 high-risk patients during a major clinical trial. The treatment uses the same mRNA technology that powered COVID-19 vaccines to teach each patient's immune system to recognize and destroy their unique cancer cells.
A personalized cancer vaccine using the same mRNA technology that powered COVID vaccines just proved it works in major trials, tripling Moderna's stock price in one day. For melanoma patients, it's the breakthrough they've been waiting for.
A personalized mRNA cancer vaccine combined with existing treatment successfully slowed melanoma's return in a groundbreaking late-stage trial. This first-of-its-kind success could open new doors for cancer patients worldwide.
A breakthrough chip recreates a patient's own brain tumor and blood vessels to test which cancer treatments will work best before they ever enter the body. Three glioblastoma patients with identical genetic tests showed completely different responses on the chip, matching their real-world outcomes.